UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000029506 |
|---|---|
| Receipt number | R000033713 |
| Scientific Title | A clinical trial of DS-8201a in HER2 positive(HER2>=1) metastatic/recurrent uterine carcinosarcoma patients (NCCH1615,STATICE trial) |
| Date of disclosure of the study information | 2017/10/11 |
| Last modified on | 2023/05/01 13:44:42 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2017/10/11 13:08:30 | ||
| 2 | Update | 2017/10/23 17:10:56 | Public title Public title Acronym Acronym |
|
| 3 | Update | 2017/10/23 17:14:47 | Public title Public title Acronym Acronym |
|
| 4 | Update | 2017/12/08 14:39:06 | Anticipated trial start date |
|
| 5 | Update | 2017/12/08 14:39:29 | Anticipated trial start date |
|
| 6 | Update | 2018/01/09 09:30:18 | Recruitment status |
|
| 7 | Update | 2018/04/12 17:20:02 | Key inclusion criteria |
|
| 8 | Update | 2018/04/12 17:24:07 | Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
| 9 | Update | 2020/02/06 17:13:08 | Interventions/Control_1 Interventions/Control_1 |
|
| 10 | Update | 2020/02/06 17:51:56 | Interventions/Control_1 |
|
| 11 | Update | 2020/06/25 14:21:13 | Recruitment status Date of IRB Last follow-up date |
|
| 12 | Update | 2020/06/25 14:24:00 | Date of IRB |
|
| 13 | Update | 2021/04/01 10:19:52 | Last follow-up date |
|
| 14 | Update | 2021/04/21 13:09:17 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
| 15 | Update | 2021/04/22 11:51:11 | UMIN ID1 |
|
| 16 | Update | 2021/04/28 12:12:35 | UMIN ID2 |
|
| 17 | Update | 2021/10/08 13:34:21 | Number of participants that the trial has enrolled |
|
| 18 | Update | 2021/10/08 14:02:27 | Email1 Organization |
|
| 19 | Update | 2021/10/13 15:31:45 | Email1 |
|
| 20 | Update | 2022/04/15 09:27:39 | Division name Division name Division name Division name Division name |
|
| 21 | Update | 2022/04/15 09:30:25 | Recruitment status |
|
| 22 | Update | 2022/04/15 09:32:03 | Target sample size |
|
| 23 | Update | 2023/05/01 13:44:42 | URL releasing protocol Publication of results URL related to results and publications Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
